Aquila Bioscience is a spin-out company from the National University of Ireland Galway founded in August 2012. AquilaBioscience is developing innovative applications of glycoscience for health and diseases and for societal security to open up new niche opportunities for the company and the region. Aquila Bioscience has been funded by the EU under FP7, H2020 programmes and with funding from the European Defence Agency.